Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial

Adherence to oral anticoagulant therapy in patients with atrial fibrillation

(2017) Roberto Cangemi et al.   THROMBOSIS AND HAEMOSTASIS

Major Bleeding Complications and Persistence With Oral Anticoagulation in Non‐Valvular Atrial Fibrillation: Contemporary Findings in Real‐Life Danish Patients

(2017) Morten Lamberts et al.   Journal of the American Heart Association

How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?

(2016) Gene R. Quinn et al.   AMERICAN JOURNAL OF CARDIOLOGY

Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin

(2016) Keitaro Senoo et al.   AMERICAN JOURNAL OF MEDICINE

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

(2016) Paulus Kirchhof et al.   EUROPEAN HEART JOURNAL

Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial

(2016) Keitaro Senoo et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes

(2016) Benjamin A. Steinberg et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study

(2016) Ziad Hijazi et al.   LANCET

Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores

(2016) Marco Proietti et al.   Scientific Reports

Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)

(2014) Emily C. O’Brien et al.   AMERICAN HEART JOURNAL

Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: Findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry

(2014) Emily C. O'Brien et al.   AMERICAN HEART JOURNAL

2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation

(2014) Atul Verma et al.   CANADIAN JOURNAL OF CARDIOLOGY

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2014) Craig T. January et al.   CIRCULATION

Additional Events in the RE-LY Trial

(2014) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studies

(2013) Neil S. Roskell et al.   EUROPACE

Bleeding Complications Associated with Warfarin Treatment in Ischemic Stroke Patients with Atrial Fibrillation: A Population-Based Cohort Study

(2013) Raymond C.S. Seet et al.   Journal of Stroke & Cerebrovascular Diseases

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Antithrombotic Therapy for Atrial Fibrillation

(2012) John J. You et al.   CHEST

Predictive Value of the HAS-BLED and ATRIA Bleeding Scores for the Risk of Serious Bleeding in a “Real-World” Population With Atrial Fibrillation Receiving Anticoagulant Therapy

(2012) Vanessa Roldán et al.   CHEST

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

(2012) Leif Friberg et al.   EUROPEAN HEART JOURNAL

Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk–Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation

(2012) Stavros Apostolakis et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review

(2011) Dan Pugh et al.   AGE AND AGEING

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation

(2011) John W. Eikelboom et al.   CIRCULATION

A New Risk Scheme to Predict Warfarin-Associated Hemorrhage

(2011) Margaret C. Fang et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Bleeding risk in ‘real world’ patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort

(2011) J. B. OLESEN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation

(2010) Gregory Y.H. Lip et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran

(2009) Michael D. Ezekowitz et al.   AMERICAN HEART JOURNAL

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE